Quest Diagnostics (DGX) Total Current Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Total Current Liabilities across 18 years of filings, most recently posting $2.2 billion for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $2.2 billion, up 51.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 51.08% YoY), and the FY2025 annual result was $2.3 billion, up 5.03% from the prior year.
• Total Current Liabilities came in at $2.2 billion for Q1 2026 at Quest Diagnostics, down from $2.3 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.3 billion in Q1 2024 to a low of $1.4 billion in Q1 2023.
• The 5-year median for Total Current Liabilities is $1.9 billion (2023), against an average of $1.9 billion.
• Across the five-year window, Total Current Liabilities surged 69.59% in 2024 and slumped 37.29% in 2025, its largest moves.
• Quest Diagnostics' Total Current Liabilities stood at $1.6 billion in 2022, then grew by 17.02% to $1.8 billion in 2023, then rose by 19.5% to $2.2 billion in 2024, then increased by 5.03% to $2.3 billion in 2025, then fell by 4.43% to $2.2 billion in 2026.
• The last three Total Current Liabilities figures came in at $2.2 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.